On June 1, 2022 argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, reported that members of management will participate in several upcoming investor conferences in June (Press release, argenx, JUN 1, 2022, View Source [SID1234615359]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies 2022 Global Healthcare Conference. Fireside chat on Wednesday, June 8, 2022 at 1:00 p.m. ET in New York, NY.

Goldman Sachs 43rd Annual Global Healthcare Conference. Fireside chat on Wednesday, June 15, 2022 at 3:20 p.m. PT in Rancho Palos Verdes, CA.

JMP Securities Life Sciences Conference. Management will participate in investor meetings on Wednesday, June 15, 2022 in New York, NY.

Additional information regarding these events will be available on the Investors section of the argenx
website at argenx.com/investors.